Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bode

Showing results (371-380 of 589) with videos related to

Pageof 59
Sort By:
Journal of Protein Chemistry|August 1, 1997
Expression, purification, characterization, and X-ray analysis of selenomethionine 215 variant of leukocyte collagenaseM Pieper, M Betz, N Budisa, et al.
Journal of the American Chemical Society|September 11, 2025
Cyclic Hydroxylamines for Native Residue-Forming Peptide Ligations: Synthesis of Ubiquitin and TirzepatideJiling Han, Kohtaro Hirao, Toshiki Mikami, et al.
Journal of Molecular Biology|December 20, 1992
Impact of protein-protein contacts on the conformation of thrombin-bound hirudin studied by comparison with the nuclear magnetic resonance solution structure of hirudin(1-51)T Szyperski, P Güntert, S R Stone, et al.
Structure (London, England : 1993)|October 6, 1999
Specific inhibition of insect alpha-amylases: yellow meal worm alpha-amylase in complex with the amaranth alpha-amylase inhibitor at 2.0 A resolutionP J Pereira, V Lozanov, A Patthy, et al.
Diabetes Technology & Therapeutics|April 5, 2011
Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trialArianne C van Bon, Bruce W Bode, Caroline Sert-Langeron, et al.
Journal of Molecular Biology|November 2, 1999
The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loopR J Dekker, A Eichinger, A A Stoop, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 30, 2015
PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALSDaniel Einhorn, Yehuda Handelsman, Bruce W Bode, et al.
Diabetes/Metabolism Research and Reviews|March 29, 2002
Diabetes management in the new millennium using insulin pump therapyBruce W Bode, Hassan T Sabbah, Todd M Gross, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 20, 2014
Stereoelectronic basis for the kinetic resolution of N-heterocycles with chiral acylating reagentsSheng-Ying Hsieh, Benedikt Wanner, Philip Wheeler, et al.
Organic Letters|May 1, 2023
Automated, Capsule-Based Suzuki-Miyaura Cross CouplingsGuillaume Coin, Tuo Jiang, Samuele Bordi, et al.
Pageof 59

Showing results (371-380 of 589) with videos related to

Sort By:
Pageof 59
Journal of Protein Chemistry|August 1, 1997
Expression, purification, characterization, and X-ray analysis of selenomethionine 215 variant of leukocyte collagenaseM Pieper, M Betz, N Budisa, et al.
Journal of the American Chemical Society|September 11, 2025
Cyclic Hydroxylamines for Native Residue-Forming Peptide Ligations: Synthesis of Ubiquitin and TirzepatideJiling Han, Kohtaro Hirao, Toshiki Mikami, et al.
Journal of Molecular Biology|December 20, 1992
Impact of protein-protein contacts on the conformation of thrombin-bound hirudin studied by comparison with the nuclear magnetic resonance solution structure of hirudin(1-51)T Szyperski, P Güntert, S R Stone, et al.
Structure (London, England : 1993)|October 6, 1999
Specific inhibition of insect alpha-amylases: yellow meal worm alpha-amylase in complex with the amaranth alpha-amylase inhibitor at 2.0 A resolutionP J Pereira, V Lozanov, A Patthy, et al.
Diabetes Technology & Therapeutics|April 5, 2011
Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trialArianne C van Bon, Bruce W Bode, Caroline Sert-Langeron, et al.
Journal of Molecular Biology|November 2, 1999
The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loopR J Dekker, A Eichinger, A A Stoop, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 30, 2015
PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALSDaniel Einhorn, Yehuda Handelsman, Bruce W Bode, et al.
Diabetes/Metabolism Research and Reviews|March 29, 2002
Diabetes management in the new millennium using insulin pump therapyBruce W Bode, Hassan T Sabbah, Todd M Gross, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 20, 2014
Stereoelectronic basis for the kinetic resolution of N-heterocycles with chiral acylating reagentsSheng-Ying Hsieh, Benedikt Wanner, Philip Wheeler, et al.
Organic Letters|May 1, 2023
Automated, Capsule-Based Suzuki-Miyaura Cross CouplingsGuillaume Coin, Tuo Jiang, Samuele Bordi, et al.
Pageof 59